Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
about
The multifaceted mast cell in inflammatory bowel diseaseSeverity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase geneCorrelation between cyclical epithelial barrier dysfunction and bacterial translocation in the relapses of intestinal inflammation.Urinary and faecal N-methylhistamine concentrations do not serve as markers for mast cell activation or clinical disease activity in dogs with chronic enteropathies.Excretion of urinary histamine and N-tele methylhistamine in patients with gastrointestinal food allergy compared to non-allergic controls during an unrestricted diet and a hypoallergenic dietSystems biology of host-microbe metabolomics.Key role of mast cells and their major secretory products in inflammatory bowel disease.Metabolomic applications to decipher gut microbial metabolic influence in health and diseaseRoles of histamine and its receptors in allergic and inflammatory bowel diseases.Activation of human colon mast cells through proteinase activated receptor-2.Modulation of tryptase secretion from human colon mast cells by histamine.Modulation of histamine release from human colon mast cells by protease inhibitors.Clinical metabolomics paves the way towards future healthcare strategies.Anti-Inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model.Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis.Histamine pharmacogenomics.Advances in mast cell biology: new understanding of heterogeneity and function.Histamine: an undercover agent in multiple rare diseases?Application of metabolomics approaches to the study of respiratory diseases.Histamine and gut mucosal immune regulation.Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism.The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritisSerum metabolomics in a Helicobacter hepaticus mouse model of inflammatory bowel disease reveal important changes in the microbiome, serum peptides, and intermediary metabolism.Sodium alginate as a novel therapeutic option in experimental colitis.Identification of urinary biomarkers of colon inflammation in IL10-/- mice using Short-Column LCMS metabolomicsNon-pulmonary allergic diseases and inflammatory bowel disease: a qualitative review.Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis.Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.Mast Cells Exert Anti-Inflammatory Effects in an IL10-/- Model of Spontaneous Colitis.
P2860
Q27026764-973CBE27-E453-4944-BF0E-F9B43C964F1CQ33788351-5E005A5E-A1DB-4115-8BCE-69CC27D5F13BQ34563741-A97C61F8-0574-4A96-B046-49AE29535DF3Q34887033-1D3F4A27-6CDE-445C-A529-D0EB51A1D305Q35321121-1900A596-FBA0-4D93-BE0D-D3BAA636BA4EQ35619563-E0E5607E-0A67-49A7-A645-7D97802C56AAQ35648042-22A85F76-13F9-4B43-99AC-F1F7938BC0DCQ35914935-2F155C53-5E6E-4245-A2D6-5984DF5EB771Q36132180-BF3295C7-79C8-48C0-B15C-000217A3989FQ36496241-F51CE72A-C4D1-4C64-AAA4-F28EDDF3A306Q36496317-1352033A-891D-4F6A-B66D-96BC481B9E0DQ36496327-B983DCE6-E4D3-4592-833D-101DB7372742Q36620171-9D3B220D-868F-4B17-960E-928F96D66AD5Q36898582-44E75AC1-A489-4539-9128-715BE5D57BD6Q37023883-C51CD34E-4C82-4A73-B856-F44B2096C73FQ37486730-C1509580-73EA-4B07-84F9-389F1CF05AE7Q37665290-5F73C79D-10F0-4CDF-A0DA-A4AECAA1C2F9Q37995651-C7383AC4-0496-4500-9B73-04F3ECB78CA3Q38050515-68597A87-A78D-43B7-B968-75FC1465F78AQ38167039-5B58AABA-BE1D-491B-9DCF-E29D6A503359Q38230162-CFAAD379-243D-45B9-92A5-E363EB96418AQ39332688-F6C740DE-63AC-484A-A3D6-20CA6D23B8E9Q39742426-E1C7FA5B-CEDA-4EA9-90F0-6C17988E0AC7Q40430564-2DBB34F3-FC66-4CFE-A4B2-46A02FA60BFCQ41305034-13642EF0-E483-402B-873F-95D21ED69E26Q42844195-6DF23AC0-C4C2-4F6F-804B-18EF9CDA2DFDQ49831846-BF12A43B-5E77-4328-89B8-1F034F2EF6EDQ54470771-7AE0C7B8-3D81-470A-A172-5F6F47D4D89FQ55064943-0BDF2BC2-EFBC-4F54-A6C2-4DFA34066A51
P2860
Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Urinary excretion of N-methylh ...... in inflammatory bowel disease.
@en
Urinary excretion of N-methylh ...... in inflammatory bowel disease.
@nl
type
label
Urinary excretion of N-methylh ...... in inflammatory bowel disease.
@en
Urinary excretion of N-methylh ...... in inflammatory bowel disease.
@nl
prefLabel
Urinary excretion of N-methylh ...... in inflammatory bowel disease.
@en
Urinary excretion of N-methylh ...... in inflammatory bowel disease.
@nl
P2093
P2860
P1476
Urinary excretion of N-methylh ...... in inflammatory bowel disease.
@en
P2093
Weidenhiller M
Winterkamp S
P2860
P304
P356
10.1111/J.1572-0241.2002.07028.X
P407
P577
2002-12-01T00:00:00Z